Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sihuan Pharmaceutical Holdings Group Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Sihuan Pharmaceutical Holdings Group Ltd (460-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Sihuan Pharmaceutical Holdings Group Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

29 Apr 2016 Wright Reports 55 $75.00

Is There Long-Term Value in Sihuan Pharmaceutical Holdings Group Ltd?

01 Mar 2016 Sadif Analytics Prime 12 $25.00

Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd. Summary Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical) is ...

25 Jan 2016 GlobalData 43 $300.00

Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd. Summary Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical) is ...

26 Nov 2015 GlobalData 46 $300.00

四环医药(00460.HK)复牌申请进展

29 Oct 2015 Guotai JunAn (HK) Research 8 $69.00

Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd. Summary Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical) is...

03 Sep 2015 GlobalData 19 $125.00

京 華 山 一 [四 環 醫 藥 (460 HK) - 維持買入 :中期業績表現正面,核心盈利增長44%](2015/09/02)

最新發展 四環藥業(460)公佈15年度中期營業額按年增長28%至17.74億元人民幣,純利增長76%至14.52億元人民幣。撇除政府補貼和出售資產收益,核心盈利增長45%至8.4億元人民幣。 投資觀點 收入增長28%,表現令人鼓舞。雖然行...

02 Sep 2015 Core Pacific - Yamaichi International (H.K.) Limited 2 $23.00

Core Pacific - Yamaichi [Sihuan Pharmaceutical (460 HK) : Maintain BUY - Solid 44% 1H15 core profit growth](2015/09/02)

What’s New Sihuan Pharm (460) announced 76% growth in 1H15 net profit to RMB1,452 mn, on the back of 28% growth in revenue t...

01 Sep 2015 Core Pacific - Yamaichi International (H.K.) Limited 2 $23.00